Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,637 | 1,128 | 1,646 | 1,919 | 9 |
| Marketable Securities | 570 | 0 | 9 | 9 | 9 |
| Inventories | 45 | N/A | 31 | 155 | 156 |
| Other current assets | 0 | 57 | 90 | 187 | 200 |
| TOTAL | $5,482 | $1,427 | $2,087 | $2,796 | $404 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 19 | 0 | 117 | 0 | 0 |
| TOTAL | $19 | $N/A | $117 | $N/A | $N/A |
| Total Assets | $5,501 | $1,427 | $2,204 | $2,796 | $404 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2 | N/A | N/A | N/A | 144 |
| Accounts payable and accrued liabilities | 238 | 127 | 115 | 73 | 106 |
| TOTAL | $327 | $142 | $122 | $80 | $266 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1 | 4 | 12 | 12 | N/A |
| Deferred Revenues | 69 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 400 | 400 |
| TOTAL | $946 | $4 | $12 | $412 | $400 |
| Total Liabilities | $1,273 | $146 | $134 | $492 | $666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,672 | 85,177 | 85,142 | 85,142 | 83,142 |
| Common Shares | 9 | 9 | 9 | 8 | 2 |
| Retained earnings | -8,097 | -5,762 | -4,973 | -4,339 | -2,895 |
| TOTAL | $4,228 | $1,281 | $2,071 | $2,304 | $-262 |
| Total Liabilities And Equity | $5,501 | $1,427 | $2,204 | $2,796 | $404 |